Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Dec-21 6:50 PM View:  | Ecor1 Capital, LLC 10% Owner | Odonate Therapeutics, Inc. (ODT) | 10-Dec-21 | Market Sale | 5,545,000 | $1.65 | $9,147,420.00 | (100%) 5.54M to 0 | (6%) |
| 10-Dec-21 6:50 PM View: | Ecor1 Capital, LLC 10% Owner | Odonate Therapeutics, Inc. (ODT) | 09-Dec-21 | Market Sale | 156,669 | $1.82 | $284,981.00 | (3%) 5.7M to 5.54M | 4% |
| 10-Dec-21 6:50 PM View: | Ecor1 Capital, LLC 10% Owner | Odonate Therapeutics, Inc. (ODT) | 01-Dec-21 | Market Purchase | 185,941 | $1.66 | $308,662.00 | 3% 5.7M to 5.89M | 5% |
| 10-Dec-21 6:50 PM View: | Ecor1 Capital, LLC 10% Owner | Odonate Therapeutics, Inc. (ODT) | 01-Dec-21 | Market Sale | 185,941 | $1.66 | $308,662.00 | (3%) 5.89M to 5.7M | (5%) |
| 24-Nov-21 6:00 PM View: | Boxer Capital, LLC 10% Owner | Odonate Therapeutics, Inc. (ODT) | 24-Nov-21 | Market Sale | 200,000 | $1.57 | $313,680.00 | (5%) 4.41M to 4.21M | 4% |
| 24-Nov-21 6:00 PM View: | Boxer Capital, LLC 10% Owner | Odonate Therapeutics, Inc. (ODT) | 22-Nov-21 | Market Sale | 200,000 | $1.55 | $309,660.00 | (4%) 4.61M to 4.41M | 3% |
| 19-Nov-21 7:22 PM View: | Davis Aaron I. Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 19-Nov-21 | Market Sale Duplicate | 150,000 | $1.84 | $276,285.00 | (3%) 5.2M to 5.05M | (< 1%) |
| 19-Nov-21 4:38 PM View: | Tang Kevin C Chief Executive Officer Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 19-Nov-21 | Market Sale | 365,289 | $1.92 | $699,930.00 | (3%) 13.13M to 12.77M | < 1% |
| 19-Nov-21 7:22 PM View: | Davis Aaron I. Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 19-Nov-21 | Market Sale | 30,000 | $1.92 | $57,495.00 | (< 1%) 5.23M to 5.2M | 3% |
| 19-Nov-21 7:21 PM View: | Boxer Capital, LLC Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 19-Nov-21 | Market Sale | 150,000 | $1.84 | $276,285.00 | (3%) 4.76M to 4.61M | (< 1%) |
| 19-Nov-21 4:38 PM View: | Tang Kevin C Chief Executive Officer Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 18-Nov-21 | Market Sale | 1,094,260 | $1.90 | $2,081,880.00 | (8%) 14.23M to 13.13M | < 1% |
| 19-Nov-21 7:22 PM View: | Davis Aaron I. Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 18-Nov-21 | Market Sale Duplicate | 250,000 | $1.95 | $487,250.00 | (5%) 5.48M to 5.23M | 5% |
| 19-Nov-21 7:21 PM View: | Boxer Capital, LLC Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 18-Nov-21 | Market Sale | 250,000 | $1.95 | $487,250.00 | (5%) 5.01M to 4.76M | 5% |
| 19-Nov-21 7:21 PM View: | Boxer Capital, LLC Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 17-Nov-21 | Market Sale | 600,000 | $2.17 | $1,299,240.00 | (11%) 5.61M to 5.01M | 15% |
| 19-Nov-21 7:22 PM View: | Davis Aaron I. Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 17-Nov-21 | Market Sale | 170,000 | $2.23 | $379,678.00 | (3%) 6.25M to 6.08M | 17% |
| 19-Nov-21 4:38 PM View: | Tang Kevin C Chief Executive Officer Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 17-Nov-21 | Market Sale | 1,287,580 | $2.29 | $2,948,750.00 | (8%) 15.51M to 14.23M | 17% |
| 19-Nov-21 7:22 PM View: | Davis Aaron I. Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 17-Nov-21 | Market Sale Duplicate | 600,000 | $2.17 | $1,299,240.00 | (10%) 6.08M to 5.48M | 15% |
| 17-Mar-21 4:04 PM View: | Hearne Michael S Chief Financial Officer | Odonate Therapeutics, Inc. (ODT) | 15-Mar-21 | Grant | 37 | $16.22 | $600.14 | < 1% 15.52M to 15.52M | |
| 17-Mar-21 4:04 PM View: | O'Connell Joseph P Chief Medical Officer | Odonate Therapeutics, Inc. (ODT) | 15-Mar-21 | Grant | 99 | $16.22 | $1,605.78 | 3% 3.51K to 3.61K | |
| 02-Mar-21 4:02 PM View: | O'Connell Joseph P Chief Medical Officer | Odonate Therapeutics, Inc. (ODT) | 26-Feb-21 | Grant | 90 | $17.89 | $1,610.10 | 3% 3.42K to 3.51K | |
| 02-Mar-21 4:03 PM View: | Hearne Michael S Chief Financial Officer | Odonate Therapeutics, Inc. (ODT) | 26-Feb-21 | Grant | 34 | $17.89 | $608.26 | < 1% 15.52M to 15.52M | |
| 17-Feb-21 4:07 PM View: | Hearne Michael S Chief Financial Officer | Odonate Therapeutics, Inc. (ODT) | 12-Feb-21 | Grant | 28 | $21.19 | $593.32 | < 1% 15.52M to 15.52M | |
| 17-Feb-21 4:06 PM View: | O'Connell Joseph P Chief Medical Officer | Odonate Therapeutics, Inc. (ODT) | 12-Feb-21 | Grant | 76 | $21.19 | $1,610.44 | 2% 3.35K to 3.42K | |
| 02-Feb-21 4:09 PM View: | O'Connell Joseph P Chief Medical Officer | Odonate Therapeutics, Inc. (ODT) | 29-Jan-21 | Grant | 82 | $19.64 | $1,610.48 | 3% 3.26K to 3.35K | |
| 02-Feb-21 4:10 PM View: | Hearne Michael S Chief Financial Officer | Odonate Therapeutics, Inc. (ODT) | 29-Jan-21 | Grant | 31 | $19.64 | $608.84 | < 1% 15.52M to 15.52M | |
| 20-Jan-21 4:01 PM View: | O'Connell Joseph P Chief Medical Officer | Odonate Therapeutics, Inc. (ODT) | 15-Jan-21 | Grant | 94 | $16.99 | $1,597.06 | 3% 3.17K to 3.26K | |
| 20-Jan-21 4:01 PM View: | Hearne Michael S Chief Financial Officer | Odonate Therapeutics, Inc. (ODT) | 15-Jan-21 | Grant | 35 | $16.99 | $594.65 | < 1% 15.52M to 15.52M | |
| 05-Jan-21 4:06 PM View: | Hearne Michael S Chief Financial Officer | Odonate Therapeutics, Inc. (ODT) | 31-Dec-20 | Grant | 350 | $16.32 | $5,712.00 | < 1% 15.52M to 15.52M | |
| 05-Jan-21 4:04 PM View: | O'Connell Joseph P Chief Medical Officer | Odonate Therapeutics, Inc. (ODT) | 31-Dec-20 | Grant | 169 | $16.32 | $2,758.08 | 6% 3.0K to 3.17K | |
| 30-Dec-20 6:18 PM View: | Davis Aaron I. Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 30-Dec-20 | Market Purchase Duplicate | 100,000 | $17.46 | $1,746,380.00 | 2% 6.15M to 6.25M | (1%) |
| 30-Dec-20 6:19 PM View: | Boxer Capital, LLC Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 30-Dec-20 | Market Purchase | 100,000 | $17.46 | $1,746,380.00 | 2% 5.51M to 5.61M | (1%) |
| 31-Dec-20 4:01 PM View: | Johnson Craig A Director | Odonate Therapeutics, Inc. (ODT) | 29-Dec-20 | Market Purchase | 3,000 | $17.00 | $51,000.00 | 100% 0 to 3.0K | 3% |
| 30-Dec-20 6:18 PM View: | Davis Aaron I. Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 29-Dec-20 | Market Purchase | 225,000 | $17.11 | $3,849,550.00 | 4% 5.93M to 6.15M | < 1% |
| 30-Dec-20 6:19 PM View: | Boxer Capital, LLC Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 28-Dec-20 | Market Purchase | 300,000 | $17.06 | $5,117,050.00 | 6% 5.21M to 5.51M | 1% |
| 30-Dec-20 6:18 PM View: | Davis Aaron I. Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 28-Dec-20 | Market Purchase | 75,000 | $16.90 | $1,267,500.00 | 1% 5.85M to 5.93M | 2% |
| 23-Dec-20 4:41 PM View: | Tang Kevin C Chief Executive Officer Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 23-Dec-20 | Market Purchase | 139,138 | $15.58 | $2,167,850.00 | < 1% 15.38M to 15.51M | 11% |
| 23-Dec-20 4:41 PM View: | Tang Kevin C Chief Executive Officer Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 22-Dec-20 | Market Purchase | 74,502 | $14.87 | $1,107,590.00 | < 1% 15.3M to 15.38M | 16% |
| 23-Dec-20 4:41 PM View: | Tang Kevin C Chief Executive Officer Director 10% Owner | Odonate Therapeutics, Inc. (ODT) | 21-Dec-20 | Market Purchase | 62,144 | $14.58 | $905,767.00 | < 1% 15.24M to 15.3M | 18% |
| 17-Dec-20 4:01 PM View: | O'Connell Joseph P Chief Medical Officer | Odonate Therapeutics, Inc. (ODT) | 15-Dec-20 | Grant | 121 | $12.91 | $1,562.11 | 4% 2.88K to 3.0K | |
| 17-Dec-20 4:01 PM View: | Hearne Michael S Chief Financial Officer | Odonate Therapeutics, Inc. (ODT) | 15-Dec-20 | Grant | 43 | $12.91 | $555.13 | < 1% 15.24M to 15.24M | |
| 02-Dec-20 4:02 PM View: | O'Connell Joseph P Chief Medical Officer | Odonate Therapeutics, Inc. (ODT) | 30-Nov-20 | Grant | 122 | $12.77 | $1,557.94 | 4% 2.76K to 2.88K | |
| 02-Dec-20 4:02 PM View: | Hearne Michael S Chief Financial Officer | Odonate Therapeutics, Inc. (ODT) | 30-Nov-20 | Grant | 45 | $12.77 | $574.65 | < 1% 15.24M to 15.24M | |
| 02-Dec-20 4:01 PM View: | Lemkey John G Chief Operating Officer | Odonate Therapeutics, Inc. (ODT) | 30-Nov-20 | Grant | 12 | $12.77 | $153.24 | < 1% 15.24M to 15.24M | |
| 17-Nov-20 4:06 PM View: | Hearne Michael S Chief Financial Officer | Odonate Therapeutics, Inc. (ODT) | 13-Nov-20 | Grant | 46 | $12.20 | $561.20 | < 1% 15.24M to 15.24M | |
| 17-Nov-20 4:04 PM View: | Lemkey John G Chief Operating Officer | Odonate Therapeutics, Inc. (ODT) | 13-Nov-20 | Grant | 96 | $12.20 | $1,171.20 | < 1% 15.24M to 15.24M | |
| 17-Nov-20 4:06 PM View: | O'Connell Joseph P Chief Medical Officer | Odonate Therapeutics, Inc. (ODT) | 13-Nov-20 | Grant | 128 | $12.20 | $1,561.60 | 5% 2.63K to 2.76K | |
| 03-Nov-20 4:05 PM View: | Lemkey John G Chief Operating Officer | Odonate Therapeutics, Inc. (ODT) | 30-Oct-20 | Grant | 96 | $12.25 | $1,176.00 | < 1% 15.24M to 15.24M | |
| 03-Nov-20 4:06 PM View: | O'Connell Joseph P Chief Medical Officer | Odonate Therapeutics, Inc. (ODT) | 30-Oct-20 | Grant | 127 | $12.25 | $1,555.75 | 5% 2.5K to 2.63K | |
| 03-Nov-20 4:06 PM View: | Hearne Michael S Chief Financial Officer | Odonate Therapeutics, Inc. (ODT) | 30-Oct-20 | Grant | 46 | $12.25 | $563.50 | < 1% 15.24M to 15.24M | |
| 19-Oct-20 4:01 PM View: | O'Connell Joseph P Chief Medical Officer | Odonate Therapeutics, Inc. (ODT) | 15-Oct-20 | Grant | 117 | $13.35 | $1,561.95 | 5% 2.38K to 2.5K |
